Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
MagstimEGI is a global leader in non-invasive brain stimulation and high-density brain monitoring technologies. Formed through the 2020 acquisition of Electrical Geodesics, Inc. (EGI) by Magstim, the company integrates Transcranial Magnetic Stimulation (TMS) with high-density Electroencephalography (EEG). Their product portfolio includes the Horizon TMS series for clinical depression treatment and the Geodesic Sensor Net for advanced neuroscience research and epilepsy mapping. MagstimEGI provides integrated solutions that allow researchers and clinicians to map brain activity and deliver targeted neuromodulation with high spatial and temporal resolution.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on MagstimEGI.